Development asset linked to Bio-Thera Solutions in public FDA and regional records.
pharma · Diabetic Macular Edema (DME)
Bio-Thera Solutions
Bio-Thera Solutions drug portfolio — 2 indexed compounds with therapeutic class and molecular targets from public FDA and regional approval metadata.
Guangzhou, CN HQ
2003 Founded
31 Employees
NMPA registrant Type
Company details
- Status
- Public
- HQ
- Guangzhou, CN
- Founded
- 2003
- Employees
- 31
- Programs
- 1
- Drugs
- 2
- Patents
- 0
Bio-Thera Solutions pipeline
Portfolio lens on 2 drugs and development assets — regulatory status, targets, and deep links to NovaPharmaNews drug profiles.
Bio-Thera Solutions drug portfolio — 2 indexed compounds with therapeutic class and molecular targets from public FDA and regional approval metadata.
Drug portfolio
-
-
US regulatory status: approved. Molecular target: Cyclooxygenase.
- Target
- Cyclooxygenase
- Mechanism
- Cyclooxygenase inhibitor